Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.
Biopharmaceutical Research Company has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Biopharmaceutical Research Company's investors include Intrinsic Capital Partners, AFI Capital Partners, Delta Emerald Ventures, Argonautic Ventures, Atacama Ventures.
Biopharmaceutical Research Company is headquartered in Castroville, United States.
Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.
Biopharmaceutical Research Company is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biopharmaceutical Research Company — Funding & Investors." VCBacked, October 4, 2022, https://www.vcbacked.co/company/biopharmaceutical-research-company. Accessed September 29, 2026.
VCBacked. (2022). Biopharmaceutical Research Company — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/biopharmaceutical-research-company
{{cite web |title=Biopharmaceutical Research Company — Funding & Investors |url=https://www.vcbacked.co/company/biopharmaceutical-research-company |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated